Epidemiology of hospitalizations associated with invasive candidiasis, United States, 2002-2012

Sara Strollo, Michail S. Lionakis, Jennifer Adjemian, Claudia Angelica Steiner, D. Rebecca Prevots

Research output: Contribution to journalArticle

Abstract

Invasive candidiasis is a major nosocomial fungal disease in the United States associated with high rates of illness and death. We analyzed inpatient hospitalization records from the Healthcare Cost and Utilization Project to estimate incidence of invasive candidiasis-associated hospitalizations in the United States. We extracted data for 33 states for 2002-2012 by using codes from the International Classification of Diseases, 9th Revision, Clinical Modification, for invasive candidiasis; we excluded neonatal cases. The overall age-adjusted average annual rate was 5.3 hospitalizations/100,000 population. Highest risk was for adults ≥65 years of age, particularly men. Median length of hospitalization was 21 days; 22% of patients died during hospitalization. Median unadjusted associated cost for inpatient care was $46,684. Age-adjusted annual rates decreased during 2005-2012 for men (annual change-3.9%) and women (annual change-4.5%) and across nearly all age groups. We report a high mortality rate and decreasing incidence of hospitalizations for this disease.

Original languageEnglish (US)
Pages (from-to)7-13
Number of pages7
JournalEmerging Infectious Diseases
Volume23
Issue number1
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

Invasive Candidiasis
Epidemiology
Hospitalization
Inpatients
Mortality
Mycoses
Incidence
International Classification of Diseases
Health Care Costs
Age Groups
Costs and Cost Analysis
Population

ASJC Scopus subject areas

  • Epidemiology
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Epidemiology of hospitalizations associated with invasive candidiasis, United States, 2002-2012. / Strollo, Sara; Lionakis, Michail S.; Adjemian, Jennifer; Steiner, Claudia Angelica; Prevots, D. Rebecca.

In: Emerging Infectious Diseases, Vol. 23, No. 1, 01.01.2017, p. 7-13.

Research output: Contribution to journalArticle

Strollo, Sara ; Lionakis, Michail S. ; Adjemian, Jennifer ; Steiner, Claudia Angelica ; Prevots, D. Rebecca. / Epidemiology of hospitalizations associated with invasive candidiasis, United States, 2002-2012. In: Emerging Infectious Diseases. 2017 ; Vol. 23, No. 1. pp. 7-13.
@article{9655905acbc5413abdeb1ae179406f3e,
title = "Epidemiology of hospitalizations associated with invasive candidiasis, United States, 2002-2012",
abstract = "Invasive candidiasis is a major nosocomial fungal disease in the United States associated with high rates of illness and death. We analyzed inpatient hospitalization records from the Healthcare Cost and Utilization Project to estimate incidence of invasive candidiasis-associated hospitalizations in the United States. We extracted data for 33 states for 2002-2012 by using codes from the International Classification of Diseases, 9th Revision, Clinical Modification, for invasive candidiasis; we excluded neonatal cases. The overall age-adjusted average annual rate was 5.3 hospitalizations/100,000 population. Highest risk was for adults ≥65 years of age, particularly men. Median length of hospitalization was 21 days; 22{\%} of patients died during hospitalization. Median unadjusted associated cost for inpatient care was $46,684. Age-adjusted annual rates decreased during 2005-2012 for men (annual change-3.9{\%}) and women (annual change-4.5{\%}) and across nearly all age groups. We report a high mortality rate and decreasing incidence of hospitalizations for this disease.",
author = "Sara Strollo and Lionakis, {Michail S.} and Jennifer Adjemian and Steiner, {Claudia Angelica} and Prevots, {D. Rebecca}",
year = "2017",
month = "1",
day = "1",
doi = "10.3201/eid2301.161198",
language = "English (US)",
volume = "23",
pages = "7--13",
journal = "Emerging Infectious Diseases",
issn = "1080-6040",
publisher = "Centers for Disease Control and Prevention (CDC)",
number = "1",

}

TY - JOUR

T1 - Epidemiology of hospitalizations associated with invasive candidiasis, United States, 2002-2012

AU - Strollo, Sara

AU - Lionakis, Michail S.

AU - Adjemian, Jennifer

AU - Steiner, Claudia Angelica

AU - Prevots, D. Rebecca

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Invasive candidiasis is a major nosocomial fungal disease in the United States associated with high rates of illness and death. We analyzed inpatient hospitalization records from the Healthcare Cost and Utilization Project to estimate incidence of invasive candidiasis-associated hospitalizations in the United States. We extracted data for 33 states for 2002-2012 by using codes from the International Classification of Diseases, 9th Revision, Clinical Modification, for invasive candidiasis; we excluded neonatal cases. The overall age-adjusted average annual rate was 5.3 hospitalizations/100,000 population. Highest risk was for adults ≥65 years of age, particularly men. Median length of hospitalization was 21 days; 22% of patients died during hospitalization. Median unadjusted associated cost for inpatient care was $46,684. Age-adjusted annual rates decreased during 2005-2012 for men (annual change-3.9%) and women (annual change-4.5%) and across nearly all age groups. We report a high mortality rate and decreasing incidence of hospitalizations for this disease.

AB - Invasive candidiasis is a major nosocomial fungal disease in the United States associated with high rates of illness and death. We analyzed inpatient hospitalization records from the Healthcare Cost and Utilization Project to estimate incidence of invasive candidiasis-associated hospitalizations in the United States. We extracted data for 33 states for 2002-2012 by using codes from the International Classification of Diseases, 9th Revision, Clinical Modification, for invasive candidiasis; we excluded neonatal cases. The overall age-adjusted average annual rate was 5.3 hospitalizations/100,000 population. Highest risk was for adults ≥65 years of age, particularly men. Median length of hospitalization was 21 days; 22% of patients died during hospitalization. Median unadjusted associated cost for inpatient care was $46,684. Age-adjusted annual rates decreased during 2005-2012 for men (annual change-3.9%) and women (annual change-4.5%) and across nearly all age groups. We report a high mortality rate and decreasing incidence of hospitalizations for this disease.

UR - http://www.scopus.com/inward/record.url?scp=85006371390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006371390&partnerID=8YFLogxK

U2 - 10.3201/eid2301.161198

DO - 10.3201/eid2301.161198

M3 - Article

C2 - 27983497

AN - SCOPUS:85006371390

VL - 23

SP - 7

EP - 13

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

SN - 1080-6040

IS - 1

ER -